<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - COVID-19 Driving Shift to Decentralized Trials
Image Overlay - COVID-19 Driving Shift to Decentralized Trials

COVID-19 Driving Shift to Decentralized Trials

COVID-19 Driving Shift to Decentralized Trials

The pandemic has meant extensive changes to all aspects of daily life, and that includes how clinical trials are conducted. COVID-19 has forced clinical trials to modernize and accommodate patients in new ways, including a shift to decentralized trials. At Yourway, we consider ourselves pioneers in decentralized and direct-to-patient trials. We’re helping to lead the charge toward a more patient-centric supply chain by providing fully integrated solutions that enable researchers and developers to bring promising therapies to market, while promoting the maintenance of patient populations by providing materials and care in a capacity convenient for them.

Back to Index
Media

Upcoming Events

Precision in Clinical Trials Summit (Boston)

May 6-7, 2024
Hilton Boston Park Plaza

Global Clinical Trial Innovation, Challenges, and Perspectives

June 6, 2024
Yourway's EU Flagship Depot in Dublin, Ireland

Media

Articles

Regulatory barriers in cross-border European pharmaceutical transport

Open chat
Come chat with us!
Hello! How can I help you?